awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41304112-820E6664-75D5-4BCF-93D3-4E4162E2A582
Q41304112-820E6664-75D5-4BCF-93D3-4E4162E2A582
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41304112-820E6664-75D5-4BCF-93D3-4E4162E2A582
Metabolic behavior prediction of pazopanib by cytochrome P450 (CYP) 3A4 by molecular docking.
P2860
Q41304112-820E6664-75D5-4BCF-93D3-4E4162E2A582
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41304112-820E6664-75D5-4BCF-93D3-4E4162E2A582
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e70ad61d0172579a1158b94dd52b16d3ada788b
P2860
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer